Summary by Moomoo AI
T2 Biosystems, Inc. (TTOO.US), a leader in the development of innovative medical diagnostic equipment, has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held on December 30, 2024. The meeting will be conducted solely via live webcast, allowing stockholders to participate, vote, and submit questions online. The company has outlined several key proposals for the meeting, including the election of three directors, Laura Adams, Robin Toft, and Seymour Liebman, to serve until the 2027 annual meeting, the approval of the amendment and restatement of the 2014 Incentive Award Plan, and the ratification of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The company is leveraging SEC rules that permit proxy materials to be furnished over the Internet, reducing environmental impact and printing costs. Stockholders of record as of November 5, 2024, are entitled to vote at the meeting. The company has emphasized the importance of stockholder votes, urging participation in the meeting or prompt voting by proxy.
